Skip to main content

Table 5 Demographics and clinical characteristics of patients with and without cardiac damage

From: Cardiac damage in patients with the severe type of coronavirus disease 2019 (COVID-19)

Variables

Mean ± SD, median (IQR), or N (%)

p Value

Cardiac damage (n = 25)

Non cardiac damage (n = 75)

Age, y

71.0 (52.0–79.5)

62.0 (49.0–67.0)

0.084

Gender

  

0.063

 Male

18 (72.0)

38 (50.7)

 

 Female

7 (28.0)

37 (49.3)

 

Comorbidities

21 (84.0)

48 (64.0)

0.061

 Hypertension

18 (72.0)

22 (29.3)

0.000

 Diabetes

9 (36.0)

12 (16.0)

0.033

 CVD

7 (28.0)

8 (10.7)

0.075

 COPD

2 (8.0)

10 (13.3)

0.722

 Malignancy

5 (20.0)

8 (10.7)

0.391

 Hypothyroidism

1 (4.0)

1 (1.3)

0.439

 Liver cirrhosis

0

3 (4.0)

0.571

 Hyperlipidemia

1 (4.0)

1 (1.3)

0.439

 Anemia

2 (8.0)

0

0.061

SBP, mmHg

135.0 (125.0–151.0)

134.0 (121.0–148.5)

0.368

DBP, mmHg

82.0 (76.0–90.0)

81.0 (72.5–92.0)

0.596

Heart Rate, bpm

89.3 ± 16.9

92.9 ± 16.3

0.351

SPO2 ≤ 93.0%§

5 (20.0)

5 (6.7)

0.124

Days from illness onset to admission

10.0 (4.0–23.5)

14.0 (8.0–28.0)

0.152

Hospitalization time, day

30.0 (18.0–50.0)

19.0 (12.8–36.5)

0.024

White blood count, × 109/L

7.6 (4.6–10.5)

5.5 (4.0–7.3)

0.020

Lymphocyte count, × 109/L

0.9 (1.3–0.7)

1.2 (0.8–1.7)

0.286

Platelet count, × 109/L

190.0 (156.0–304.0)

227.0 (170.0–297.0)

0.389

Hemoglobin, g/L

115.1 ± 27.3

120.5 ± 17.4

0.381

Prothrombin time, s

14.3 (13.5–15.4)

13.9 (13.3–14.2)

0.029

Activated partial thromboplastin time, s

39.2 (37.2–45.4)

39.1 (35.7–42.2)

0.566

Fibrinogen, g/L

4.88 ± 1.70

119.2 ± 20.2

0.681

D-dimer, mg/L

2.44 (1.03–8.29)

1.01 (0.40–2.69)

0.008

Alanine aminotransferase, U/L

25.5 (12.0–44.0)

19.0 (12.0–38.8)

0.463

Creatinine, μmol/L

79.0 (64.0–94.8)

64.0 (55.0–80.5)

0.022

Procalcitonin, ng/ml

0.08 (0.05–0.23)

0.06 (0.03–0.09)

0.013

Interleukin-6, pg/ml

26.23 (6.09–46.06)

6.08 (2.54–14.15)

0.002

Ferritin, ng/ml

669.2 (332.9–992.9)

457.6 (303.3–1292.6)

0.773

hsCRP, mg/ml

39.4 (10.2–79.6)

8 (2.4–41.7)

0.019

Influenza A antibody

1 (4.0)

4 (5.3)

1.000

Death

0

4 (5.3)

0.556

  1. §Oxygen saturation was measured on admission after receiving oxygen therapy. COVID-19 = coronavirus disease 2019; COPD = chronic obstructive pulmonary disease; CVD = cardiovascular disease; SBP = systolic blood pressure; DBP = diastolic blood pressure; hsCRP = hypersensitive C-reactive protein